EE05064B1 - Meetod tuntud tetrasooli derivaadi snteesiks - Google Patents

Meetod tuntud tetrasooli derivaadi snteesiks

Info

Publication number
EE05064B1
EE05064B1 EEP200200460A EEP200200460A EE05064B1 EE 05064 B1 EE05064 B1 EE 05064B1 EE P200200460 A EEP200200460 A EE P200200460A EE P200200460 A EEP200200460 A EE P200200460A EE 05064 B1 EE05064 B1 EE 05064B1
Authority
EE
Estonia
Prior art keywords
compound
formula
reaction mixture
synthesis
tetrazole derivative
Prior art date
Application number
EEP200200460A
Other languages
English (en)
Estonian (et)
Inventor
βnos Fischer J
Ball Ildik
Pet�nyi Endr�n�
βnos Kreidl J
βszl� Czibula L
βs Nemes Andr
Deutschn� Juh βsz Ida
Werkn Papp Va
Nagyn Bagdy Judit
βn Hegedus Istv
Farkas Jen�n�
Original Assignee
Richter Gedeon Vegy�szeti Gy βr Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegy�szeti Gy βr Rt. filed Critical Richter Gedeon Vegy�szeti Gy βr Rt.
Publication of EE200200460A publication Critical patent/EE200200460A/xx
Publication of EE05064B1 publication Critical patent/EE05064B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EEP200200460A 2000-04-21 2001-04-20 Meetod tuntud tetrasooli derivaadi snteesiks EE05064B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0001618A HU222773B1 (hu) 2000-04-21 2000-04-21 Eljárás egy ismert tetrazolszármazék előállítására
PCT/HU2001/000047 WO2001081336A1 (en) 2000-04-21 2001-04-20 Process for the synthesis of a known tetrazol derivative

Publications (2)

Publication Number Publication Date
EE200200460A EE200200460A (et) 2003-12-15
EE05064B1 true EE05064B1 (et) 2008-08-15

Family

ID=89978280

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200460A EE05064B1 (et) 2000-04-21 2001-04-20 Meetod tuntud tetrasooli derivaadi snteesiks

Country Status (17)

Country Link
US (1) US6710183B2 (de)
EP (1) EP1274702B1 (de)
JP (1) JP2003531203A (de)
AT (1) ATE259366T1 (de)
AU (1) AU2001254998A1 (de)
BG (1) BG65699B1 (de)
CZ (1) CZ301029B6 (de)
DE (1) DE60102008T2 (de)
EA (1) EA004633B1 (de)
EE (1) EE05064B1 (de)
ES (1) ES2215130T3 (de)
HU (1) HU222773B1 (de)
PL (1) PL198664B1 (de)
SK (1) SK286740B6 (de)
TR (1) TR200401058T4 (de)
UA (1) UA72803C2 (de)
WO (1) WO2001081336A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21236A (sl) * 2001-05-18 2003-12-31 Aurobindo Pharma Limited Postopek kristalizacije losartan kalija
US7041832B2 (en) * 2002-04-29 2006-05-09 Tava Pharmaceutical Industries, Ltd. Processes for preparing losartan and losartan potassium
AU2003278422A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Amorphous form of losartan potassium
AU2003269470A1 (en) * 2003-04-03 2004-10-25 Ipca Laboratories Limited A process for the synthesis of losartan potassium
US6916935B2 (en) * 2003-05-06 2005-07-12 Ipca Laboratories Losartan potassium synthesis
US7345071B2 (en) 2003-05-07 2008-03-18 Ipca Laboratories Limited Process for the synthesis of Losartan potassium
WO2005066158A2 (en) * 2004-01-06 2005-07-21 Ipca Laboratories Limited An improved process for the synthesis of losartan potassium
WO2006050922A1 (en) 2004-11-11 2006-05-18 Lek Pharmaceuticals D.D. Process for the synthesis of tetrazoles
ITTO20060560A1 (it) * 2006-07-27 2008-01-28 S I M S S R L Composti intermedi per la preparazione di antagonisti dell¿angiotensina ii
ES2397284T3 (es) * 2006-08-22 2013-03-06 Ranbaxy Laboratories Limited Proceso para preparar inhibidores de la metaloproteinasa de la matriz y auxiliares quirales para los mismos
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US11327065B1 (en) * 2021-08-27 2022-05-10 Jubilant Generics Limited Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4221583A1 (de) * 1991-11-12 1993-05-13 Bayer Ag Substituierte biphenylpyridone
US5206374A (en) * 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
DE69233734D1 (de) * 1991-11-18 2008-06-26 Du Pont 2-(2'-Triphenylmethyl-2'H-tetrazol-5'-yl)phenylborsäure als Zwischenprodukt zur Synthese von A II Receptorenantagonisten
WO1995017396A1 (en) 1993-12-23 1995-06-29 Merck & Co., Inc. Polymorphs of losartan and the process for the preparation of form ii of losartan
CA2186606A1 (en) * 1994-03-29 1995-10-05 Edward B. Nelson Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
ES2105939B1 (es) * 1994-08-02 1998-07-01 Uriach & Cia Sa J Nuevos pirazoles con actividad antagonista de la angiotensina ii.

Also Published As

Publication number Publication date
ES2215130T3 (es) 2004-10-01
EP1274702A1 (de) 2003-01-15
HUP0001618A2 (hu) 2002-11-28
SK12892002A3 (sk) 2002-12-03
BG65699B1 (bg) 2009-07-31
US20030078435A1 (en) 2003-04-24
ATE259366T1 (de) 2004-02-15
DE60102008T2 (de) 2004-12-09
WO2001081336A1 (en) 2001-11-01
HU0001618D0 (en) 2000-06-28
AU2001254998A1 (en) 2001-11-07
JP2003531203A (ja) 2003-10-21
PL198664B1 (pl) 2008-07-31
US6710183B2 (en) 2004-03-23
BG107031A (en) 2003-08-29
EP1274702B1 (de) 2004-02-11
EA200201122A1 (ru) 2003-04-24
EA004633B1 (ru) 2004-06-24
EE200200460A (et) 2003-12-15
UA72803C2 (en) 2005-04-15
HU222773B1 (hu) 2003-10-28
TR200401058T4 (tr) 2004-06-21
WO2001081336A8 (en) 2002-08-29
DE60102008D1 (de) 2004-03-18
PL356929A1 (en) 2004-07-12
CZ301029B6 (cs) 2009-10-14
SK286740B6 (sk) 2009-04-06

Similar Documents

Publication Publication Date Title
ZA200202568B (en) Process for the synthesis of silicoaluminophosphate molecular sieves.
NZ598172A (en) Synthesis of boronic ester and acid compounds
EE05064B1 (et) Meetod tuntud tetrasooli derivaadi snteesiks
WO2006004100A8 (ja) １，２－ジヒドロピリジン－２－オン化合物の製造方法
IL166628A0 (en) Dehydrophenyl lahistins and analogs thereof and the synthesis of dehydrophenyllahistins and analogs thereof
BR0213814A (pt) Processos para a fabricação de 3-hidroxi-n, 1,6-trialquil-4-oxo-1, 4-diidro piridino-2-carboxamida
CO4700282A1 (es) Compuestos
NZ544004A (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EP0713873A3 (de) Aminocyclopentan-Derivate
FR2846325B1 (fr) Nouveau procede de preparation d'un intermediaire de synthese de pesticide
EP0970947A4 (de) Verfahren zur herstellung von buttersäureester-derivaten
DK1567510T3 (da) Fremgangsmåde til fremstilling af salte af tolperison
EP1484311A4 (de) Verfahren zur herstellung von kettenoligomilchsäureester
PT1030838E (pt) Metodo de sintese de pirrolamidas
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
EP0739885A4 (de) Verfahren zur herstellung von 3-isoxazol carbonsäure
ATE548366T1 (de) Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen
ITMI20040501A1 (it) Procedimento per la preparazione della monoaamide dell'acrido ciclosendiacetico
WO2000052012A3 (en) A method for synthesizing porphyrin compounds
MXPA05008179A (es) Procedimiento para la fabricacion de alcaloides de quinazolina.
WO2007104793A3 (en) Process for preparing l-nucleic acid derivatives and intermediates thereof
SE0103558D0 (sv) Novel recoverable squaric acid mono esters in bioconjugation chemistry
JPS5479283A (en) Preparation of fluoroalkyl pyridine
JP4159767B2 (ja) ラクトンの製造方法
UA67370A (en) A method for the preparation of bis (methylthio) methane

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20120420